























































an essential skill in an era of novel technologies
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This editorial refers to ‘The photoplethysmography diction-
ary: practical guidance on signal interpretation and clinical
scenarios from TeleCheck-AF’, by R.M.J. van der Velden
et al. doi: 10.1093/ehjdh/ztab050.
Introduction
Innovations in smart wearables and mHealth have provided avenues
in screening and monitoring of cardiovascular health at a population
wide level. With the disruption to conventional healthcare during the
coronavirus-19 (COVID-19) pandemic, the role of remote monitor-
ing and management of different health conditions have accelerated
and have taken a huge step forward, providing clinicians with many
novel devices to support these endeavours.
The TeleCheck-AF study is a multicentre study utilizing photople-
thysmography (PPG) technology through a built-in camera allowing
semi-continuous heart rate and rhythm monitoring for patients with
atrial fibrillation (AF).1 Despite the widespread use of PPG-based
technology, clinicians and health care providers have not been intro-
duced to it formally and in a structured way like in the case of electro-
cardiograms (ECGs).
In this issue of the journal, the TeleCheck-AF investigators pro-
vided, based on their experience, a structured stepwise practical
guide on evaluating and interpreting PPG signals. This comprises of a
simple five-step approach: (i) checking the quality of tracing, (ii)
checking the output of the PPG FibriCheckVC algorithm, (iii) checking
for regularity, (iv) checking medical history to increase likeliness of ar-
rhythmia and increase pre-test probability, and (v) proceeding with
further diagnostic testing and therapy as indicated.1
Apart from this, the investigators also shared some common clinic-
al scenarios to help clinicians better understand the application in real
life, including the important limitations of PPG such as the inability to
differentiate between regular tachycardias and the requirements for
ECG documentation for the final diagnosis.
This is a pertinent topic, with the current rapid advancements and
adoption of novel devices into routine clinical practice. It certainly
appears that the integration of practical guides of interpretation of
PPG into the medical curriculum, similar to that of ECG interpret-
ation, may not be too far in the future of medical education.
Where do we go from here?
Artificial intelligence (AI) algorithms were used in TeleCheck-AF to
determine which patients were clearly in AF. Those where the diag-
nosis was uncertain were then checked for regularity. Nonetheless,
clinicians should be provided with the knowledge to interpret the
results of these devices not only to double-check the interpretation
of the algorithm but also to unravel the enigma surrounding new
technology. Also, the future of medical education goes beyond the
skill of PPG interpretation and, whilst not explicitly tackled in van der
Velden et al.,1 is a current theme that runs throughout.
The use of AI to assist with interpretation should not be a deter-
rent for healthcare professionals to learn its interpretation. Indeed,
there has been an exponential growth in AI use the diagnosis and risk
assessment of patients with AF.2 Indeed, AI has also been applied to
help improve stroke risk stratification, accounting for dynamic
changes in stroke risks.3,4
The bottom line is that AI and in silico medical technologies, along
with robotics and medical devices, are developing at a rapid pace.
Undoubtedly, these new technologies will play a vital role in the
future of medicine, as will the ability to understand their use and
limitations. Hence, medical education must expand to incorporate
the use and assessment of novel technologies in clinical settings.
While attitudes to new technologies are on the whole positive,
uptake of these technologies remains poor, primarily due to a lack of
knowledge of the technology and discomfort when using them.5,6
The TeleCheck-AF project is therefore an important step towards
bridging that knowledge gap and developing familiarity with PPG
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..rhythm interpretation. Without these initiatives to enhance adoption,
the technology itself is ineffectual, and as such this is a crucial step in
the improvement of digital health provision.
For the successful adoption of novel technologies, it is not only suf-
ficient that there is robust evidence to support their clinical use
(Figure 1). The successful application of mobile health (mHealth) tech-
nologies to improve patient care in AF has been in the mAFA-II trial,
which was a cluster randomized trial comparing the ABC (Atrial fib-
rillation Better Care) pathway against usual care, resulting in a signifi-
cant reduction in stroke/thromboembolism, mortality and bleeding
with the mAFA App-based intervention.7 Importantly, the long-term
extension cohort showed a high adherence (>70%) and persistence
(>90%) of use.8 This is important given that ABC pathway compli-
ance has major implications for reducing mortality and morbidity
from stroke, major bleeding and hospitalizations.9,10
Nonetheless, healthcare professionals must also understand the
use of the technology and its limitations. The limitations are particu-
larly important as this will create clear bounds of use. Beyond an
understanding of the technology and the limitations of its use, data se-
curity, ownership, and access are crucial aspects of technology inte-
gration that are needed to build trust. Again, this is an area where
technology can help, through the use of blockchain for example.11
Care must also be taken to avoid the exacerbation of existing health
inequalities through the adoption of digital healthcare solutions. It is
sobering to remember that just under half the world’s population has
no access to the internet12 and that lack of internet access is associ-
ated with poorer health.13
Taken together, strong evidence, strong data security, a
workforce that is familiar and understands the technology, along with
a focus on healthcare equity and equality, all combine to accelerate
the successful adoption of these novel healthcare technologies. Time
will tell.
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